4
Changes in Ownership
PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-24-000016
Chief Business Officer acquired 31,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hull Hans Chief Business Officer | 2024-01-23 | Grant or award | +31,500 | 216,569 | D | ||
| Derivatives | |||||||
| Hull Hans Chief Business Officer | 2024-01-23 | Grant or award · Stock Option (Right to Buy) | +63,000 | 63,000 | D | ||
Loading xslF345X05/wk-form4_1706133455.xml…